ARQT Competitors & Alternatives
Compare Arcutis Biotherapeutics Inc with similar stocks in the same industry
Biotechnology
ARQT
Main Stock$32.20
Tradestie Score
41
Market Cap
$2.37B
P/E Ratio
151.8
Revenue Growth
0.6%
Analyst Upside
+21.5%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$139.53
|
$3.98B | 134.1 | 64 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$110.85
|
$3.91B | - | 58 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$22.04
|
$3.83B | - | 54 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$14.92
|
$3.68B | - | 47 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$83.10
|
$3.67B | - | 68 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$10.95
|
$3.59B | 15.7 | 26 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$20.31
|
$3.58B | 9.1 | 66 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$307.82
|
$3.49B | 33.2 | 46 | Compare |
More ARQT Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry